These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 10891407)

  • 1. Neutralization and enhancement of HIV-1 infection by sera from HIV-1 infected individuals who progress to disease at different rates.
    Jolly PE; Weiss HL
    Virology; 2000 Jul; 273(1):52-9. PubMed ID: 10891407
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIV-1 gp120-specific antibody-dependent cell-mediated cytotoxicity correlates with rate of disease progression.
    Baum LL; Cassutt KJ; Knigge K; Khattri R; Margolick J; Rinaldo C; Kleeberger CA; Nishanian P; Henrard DR; Phair J
    J Immunol; 1996 Sep; 157(5):2168-73. PubMed ID: 8757343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A longitudinal study of neutralizing antibodies and disease progression in HIV-1-infected subjects.
    Cecilia D; Kleeberger C; Muñoz A; Giorgi JV; Zolla-Pazner S
    J Infect Dis; 1999 Jun; 179(6):1365-74. PubMed ID: 10228056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effector HIV-specific cytotoxic T-lymphocyte activity in long-term nonprogressors: associations with viral replication and progression.
    Keoshkerian E; Ashton LJ; Smith DG; Ziegler JB; Kaldor JM; Cooper DA; Stewart GJ; Ffrench RA
    J Med Virol; 2003 Dec; 71(4):483-91. PubMed ID: 14556259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibodies to conserved epitopes of the HIV-1 envelope in sera from long-term non-progressors: prevalence and association with neutralizing activity.
    Braibant M; Brunet S; Costagliola D; Rouzioux C; Agut H; Katinger H; Autran B; Barin F
    AIDS; 2006 Oct; 20(15):1923-30. PubMed ID: 16988513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of enhancement of caprine arthritis encephalitis virus infection in monocyte-derived macrophage cultures by sera from goats that developed severe arthritis after vaccination and virus challenge.
    Gangopadhyay A; Jolly PE
    Cell Mol Biol (Noisy-le-grand); 2003 Nov; 49(7):1177-82. PubMed ID: 14682401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autologous neutralizing antibodies prevail in HIV-2 but not in HIV-1 infection.
    Björling E; Scarlatti G; von Gegerfelt A; Albert J; Biberfeld G; Chiodi F; Norrby E; Fenyö EM
    Virology; 1993 Mar; 193(1):528-30. PubMed ID: 8438591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification and characterization of sera from HIV-infected individuals with broad cross-neutralizing activity against group M (env clade A-H) and group O primary HIV-1 isolates.
    Beirnaert E; Nyambi P; Willems B; Heyndrickx L; Colebunders R; Janssens W; van der Groen G
    J Med Virol; 2000 Sep; 62(1):14-24. PubMed ID: 10935983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High level serum neutralizing antibody against HIV-1 in Chinese long-term non-progressors.
    Wang Q; Shang H; Han X; Zhang Z; Jiang Y; Wang Y; Dai D; Diao Y
    Microbiol Immunol; 2008 Apr; 52(4):209-15. PubMed ID: 18426395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular and cellular interactions of HIV-1/HTLV coinfection and impact on AIDS progression.
    Casoli C; Pilotti E; Bertazzoni U
    AIDS Rev; 2007; 9(3):140-9. PubMed ID: 17982939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreasing sensitivity to RANTES (regulated on activation, normally T cell-expressed and -secreted) neutralization of CC chemokine receptor 5-using, non-syncytium-inducing virus variants in the course of human immunodeficiency virus type 1 infection.
    Koning FA; Kwa D; Boeser-Nunnink B; Dekker J; Vingerhoed J; Hiemstra H; Schuitemaker H
    J Infect Dis; 2003 Sep; 188(6):864-72. PubMed ID: 12964118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The HLA-B*5703 allele confers susceptibility to the development of spondylarthropathies in Zambian human immunodeficiency virus-infected patients with slow progression to acquired immunodeficiency syndrome.
    López-Larrea C; Njobvu PD; González S; Blanco-Gelaz MA; Martínez-Borra J; López-Vázquez A
    Arthritis Rheum; 2005 Jan; 52(1):275-9. PubMed ID: 15641063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antigen-specific beta-chemokine production and CD8 T-cell noncytotoxic antiviral activity in HIV-2-infected individuals.
    Ahmed RK; Norrgren H; da Silva Z; Blaxhult A; Fredriksson EL; Biberfeld G; Andersson S; Thorstensson R
    Scand J Immunol; 2005 Jan; 61(1):63-71. PubMed ID: 15644124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neutralizing antibody patterns and viral escape in HIV-1 non-B subtype chronically infected treatment-naive individuals.
    Kelly HR; Urbanski M; Burda S; Zhong P; Konings F; Nanfack J; Tongo M; Kinge T; Achkar J; Nyambi P
    Hum Antibodies; 2005; 14(3-4):89-99. PubMed ID: 16720979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of neutralizing antibodies in HIV infection.
    Humbert M; Dietrich U
    AIDS Rev; 2006; 8(2):51-9. PubMed ID: 16848273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Binding antibody to neutralizing epitope gp41 in HIV-1 subtype CRF 01_AE infection related to stage of disease.
    Srisurapanon S; Louisirirotchanakul S; Sumransurp K; Ratanasrithong M; Chuenchitra T; Jintakatkorn S; Wasi C
    Southeast Asian J Trop Med Public Health; 2005 Jan; 36(1):221-7. PubMed ID: 15906673
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence for an antiviral effect and interferon neutralizing capacity in human sera; variability and implications for HIV infection.
    Fall LS; Chams V; Le Coq H; Fouchard M; M'Bika JP; Gringeri A; Santagostino E; Bizzini B
    Cell Mol Biol (Noisy-le-grand); 1995 May; 41(3):409-16. PubMed ID: 7580835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of virus-specific CD8(+) effector T cells in the course of HIV-1 infection: longitudinal analyses in slow and rapid progressors.
    Jansen CA; Piriou E; Bronke C; Vingerhoed J; Kostense S; van Baarle D; Miedema F
    Clin Immunol; 2004 Dec; 113(3):299-309. PubMed ID: 15507395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suggestion of nonlinear or phasic progression of knee osteoarthritis based on measurements of serum cartilage oligomeric matrix protein levels over five years.
    Sharif M; Kirwan JR; Elson CJ; Granell R; Clarke S
    Arthritis Rheum; 2004 Aug; 50(8):2479-88. PubMed ID: 15334461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunologic response to HIV.
    Hay C; Rosenberg E
    AIDS Clin Care; 1998 Jan; 10(1):1-3. PubMed ID: 11365074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.